This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

BD's Latest Pen Needle Innovation Designed To Make Injections Easier For People With Diabetes

FRANKLIN LAKES, N.J., June 21, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. launch of the BD Ultra-Fine™ Nano™ 4mm Pen Needle with EasyFlow™ Technology. EasyFlow Technology makes it easier and faster for people with diabetes to give themselves their daily insulin injections. Product demonstrations will be taking place in the BD booth at the American Diabetes Association 73rd Scientific Sessions on June 21 – 25, 2013 in Chicago.

(Photo:  http://photos.prnewswire.com/prnh/20130621/NY36093-INFO )

Insulin is a life-saving drug for those unable to regulate their blood sugar levels. For many people with diabetes, this means they will take the medication for the rest of their lives, often with multiple injections per day. People with diabetes recognize the impact of BD's latest innovation on their daily injection experience, with a majority preferring BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology to their current pen needle on all three of the leading insulin pen brands.[1] In a clinical study published in Clinical Therapeutics, 61% of patients reported they needed less thumb force to inject,[1] and 49% of patients reported less time to inject than with their usual pen needle.[1] BD is able to deliver this improved performance by increasing the space inside the needle while maintaining industry leading gauge size – increasing the flow rate in controlled laboratory testing by up to 149% versus competitive pen needles.[1]

The launch of EasyFlow Technology is the latest example of BD's commitment to improving injections for people with diabetes. It follows BD's recent launch of PentaPoint™ Comfort, a patented 5-bevel needle tip clinically proven to enhance comfort.[2] Both of these innovations are now included in BD's shortest and thinnest pen needle, the BD Ultra-Fine Nano 4mm Pen Needle.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,214.42 -10.15 -0.06%
S&P 500 2,110.74 -3.12 -0.15%
NASDAQ 4,987.89 +20.7530 0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs